Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sylvia Mahara

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Annals of Translational Medicine|April 1, 2017
Targeting the seeds of small cell lung cancerSylvia Mahara, Ron Firestein
Cell Cycle (Georgetown, Tex.)|July 27, 2016
Molecular switch of EZH2 in hypoxiaSylvia Mahara, Wee Joo Chng, Qiang Yu
Proceedings of the National Academy of Sciences of the United States of America|June 16, 2016
HIFI-α activation underlies a functional switch in the paradoxical role of Ezh2/PRC2 in breast cancerSylvia Mahara, Puay Leng Lee, Min Feng, et al.
Molecular Cell|October 30, 2024
Transient promoter interactions modulate developmental gene activationSylvia Mahara, Sonja Prüssing, Valeriia Smialkovska, et al.
Blood|July 8, 2011
The histone methyltransferase inhibitor, DZNep, up-regulates TXNIP, increases ROS production, and targets leukemia cells in AMLJianbiao Zhou, Chonglei Bi, Lip-Lee Cheong, et al.
Molecular Cancer|September 22, 2012
The pro-metastasis tyrosine phosphatase, PRL-3 (PTP4A3), is a novel mediator of oncogenic function of BCR-ABL in human chronic myeloid leukemiaJianbiao Zhou, Lip-Lee Cheong, Shaw-Cheng Liu, et al.
Science Advances|June 17, 2021
Genome-scale CRISPR-Cas9 screen of Wnt/β-catenin signaling identifies therapeutic targets for colorectal cancerChunhua Wan, Sylvia Mahara, Claire Sun, et al.
Plos One|May 19, 2011
PRL-3, a metastasis associated tyrosine phosphatase, is involved in FLT3-ITD signaling and implicated in anti-AML therapyJianbiao Zhou, Chonglei Bi, Wee-Joo Chng, et al.
Molecular Cell|December 15, 2021
MED12 and BRD4 cooperate to sustain cancer growth upon loss of mediator kinaseDhanya Sooraj, Claire Sun, Anh Doan, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 13, 2018
Hypoxic tumor microenvironment activates GLI2 via HIF-1α and TGF-β2 to promote chemoresistance in colorectal cancerYen-An Tang, Yu-Feng Chen, Yi Bao, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Annals of Translational Medicine|April 1, 2017
Targeting the seeds of small cell lung cancerSylvia Mahara, Ron Firestein
Cell Cycle (Georgetown, Tex.)|July 27, 2016
Molecular switch of EZH2 in hypoxiaSylvia Mahara, Wee Joo Chng, Qiang Yu
Proceedings of the National Academy of Sciences of the United States of America|June 16, 2016
HIFI-α activation underlies a functional switch in the paradoxical role of Ezh2/PRC2 in breast cancerSylvia Mahara, Puay Leng Lee, Min Feng, et al.
Molecular Cell|October 30, 2024
Transient promoter interactions modulate developmental gene activationSylvia Mahara, Sonja Prüssing, Valeriia Smialkovska, et al.
Blood|July 8, 2011
The histone methyltransferase inhibitor, DZNep, up-regulates TXNIP, increases ROS production, and targets leukemia cells in AMLJianbiao Zhou, Chonglei Bi, Lip-Lee Cheong, et al.
Molecular Cancer|September 22, 2012
The pro-metastasis tyrosine phosphatase, PRL-3 (PTP4A3), is a novel mediator of oncogenic function of BCR-ABL in human chronic myeloid leukemiaJianbiao Zhou, Lip-Lee Cheong, Shaw-Cheng Liu, et al.
Science Advances|June 17, 2021
Genome-scale CRISPR-Cas9 screen of Wnt/β-catenin signaling identifies therapeutic targets for colorectal cancerChunhua Wan, Sylvia Mahara, Claire Sun, et al.
Plos One|May 19, 2011
PRL-3, a metastasis associated tyrosine phosphatase, is involved in FLT3-ITD signaling and implicated in anti-AML therapyJianbiao Zhou, Chonglei Bi, Wee-Joo Chng, et al.
Molecular Cell|December 15, 2021
MED12 and BRD4 cooperate to sustain cancer growth upon loss of mediator kinaseDhanya Sooraj, Claire Sun, Anh Doan, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 13, 2018
Hypoxic tumor microenvironment activates GLI2 via HIF-1α and TGF-β2 to promote chemoresistance in colorectal cancerYen-An Tang, Yu-Feng Chen, Yi Bao, et al.
Pageof 2